Taconic Biosciences adds Dr Frank Sistare to Scientific Advisory Board

KUALA LUMPUR, Oct 18 -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions has added Dr Frank Sistare to its Scientific Advisory Board (SAB).

Dr Sistare joins existing SAB members Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD, according to a statement.

The SAB will continue to collaborate with Taconic’s management in providing scientific insight and guidance on the evolution of its product and service portfolio.

Dr Sistare’s extensive career and expertise in the field of toxicology complements the standing board members as it provides expertise in microbiome, oncology and toxicology spaces to drive Taconic’s innovation in these and other research areas.

“We welcome Dr Sistare and his deep experience as Taconic continues developing solutions that are more precise and relevant to human clinical outcomes,” shared Taconic Biosciences chief executive officer, Nancy J. Sandy.

Dr Sistare has served for the past 16 years as executive director, associate vice-president and scientific associate vice-president within safety assessment and laboratory animal resources at Merck Research Laboratories.

He earned his BS in Pharmacy from the University of Rhode Island, PhD in Pharmacology at the University of Virginia, and was awarded a postdoctoral PRAT Fellowship at the National Institutes of Health.

-- BERNAMA